Total Funding
93
89
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
13669
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Cary Claiborne: Chief Executive OfficerPast Role: Adial Pharmaceuticals, Chief Operating Officer
Bankole Johnson: Chairman
About the Company
Adial Pharmaceuticals engages in the development of prescription medications for addiction and related disorders in the United States. The company's research pipeline includes AD04, a compound that completed the Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed the Phase I clinical-stage for treating
addictive behaviors.
